Literature DB >> 8383864

Small hepatocellular carcinoma: MR follow-up of treatment with percutaneous ethanol injection.

S Sironi1, T Livraghi, E Angeli, A Vanzulli, G Villa, E Colombo, G Taccagni, A DelMaschio.   

Abstract

To assess the potential role of magnetic resonance (MR) imaging in the follow-up evaluation of small hepatocellular carcinoma (HCC) treated with percutaneous ethanol injection (PEI), 31 patients with a single HCC lesion less than 3.0 cm in diameter underwent MR imaging at 0.5 T before and after treatment. Posttreatment follow-up included contrast material-enhanced computed tomography (CT) and fine-needle biopsy in all cases. The most important characteristic of the treated HCC lesions was hypointensity on T2-weighted MR images in cases (27 of 31) in which complete tumor necrosis was achieved with PEI. This feature corresponded to a nonenhanced, low-attenuation area on follow-up contrast-enhanced CT scans. Four HCCs were positive for malignant cells at 6-month fine-needle biopsy; in these lesions, residual tumor tissue was of high signal intensity on T2-weighted MR images and of high attenuation on contrast-enhanced CT scans. In each case, incomplete tumor necrosis was confirmed at pathologic examination of the surgical specimen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383864     DOI: 10.1148/radiology.187.1.8383864

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

Review 1.  Ethanol injection for the treatment of hepatic tumours.

Authors:  C Bartolozzi; R Lencioni
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 2.  [Minimally invasive techniques for treatment of metastatic cancer].

Authors:  R Capanna; P De Biase; L Sensi
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

3.  MRI in detection of hepatocellular carcinoma (HCC).

Authors:  Subba R Digumarthy; Dushyant V Sahani; Sanjay Saini
Journal:  Cancer Imaging       Date:  2005-04-13       Impact factor: 3.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.